Enveric Biosciences Inc

NASDAQ:ENVB  
2.17
-0.06 (-2.69%)
Mergers / Acquisitions

Enveric Biosciences Announces Definitive Agreement To Acquire Magicmed Industries

Published: 05/24/2021 10:51 GMT
Enveric Biosciences Inc (ENVB) - Enveric Biosciences Announces Definitive Agreement to Acquire Magicmed Industries, a Pharmaceutical Drug Discovery and Development Platform Focused on New-generation Psychedelic Molecular Compounds and Derivatives.
Enveric Biosciences Inc - Upon Closing, Joseph Tucker Will Be Appointed Co's CEO and David Johnson As Executive Chairman.
Enveric Biosciences Inc - at Closing, Recently Formed Unit of Enveric Will Amalgamate With Magicmed.
Enveric Biosciences Inc - Corporation Resulting From Merger to Be Indirect Wholly Owned Unit of Co.
Enveric Biosciences Inc - to Issue Shareholders of Magicmed 9.9 Million Shares, Warrants, Options, Restricted Stock Units.
Enveric Biosciences Inc - Current Enveric Shareholders Will Own About 63.4% of Combined Company's Common Stock.